Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian-Chao Cheng

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Advances in assays of matrix metalloproteinases (MMPs) and their inhibitorsXian-Chao Cheng, Hao Fang, Wen-Fang Xu
Current Medicinal Chemistry|February 22, 2008
Role of sulfonamide group in matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Current Medicinal Chemistry|February 22, 2008
Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffoldXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Bromo-1-(3-chloro-pyridin-2-yl)-N-(4-eth-oxy-phen-yl)-1H-pyrazole-5-carbox-amideHai Yue, Wei-Li Dong, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Hy-droxy-methyl-1-(4-meth-oxy-phen-yl)imidazolidine-2,4-dioneXian-Chao Cheng, Jing-Jing Hou, Run-Ling Wang, et al.
European Journal of Medicinal Chemistry|March 26, 2008
Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Methyl 4-(cyclopropylmethoxy)-3-hydroxybenzoate [corrected]Jing-Jing Hou, Xian-Chao Cheng, Run-Ling Wang, et al.
Bioorganic & Medicinal Chemistry|August 23, 2008
Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Bioorganic & Medicinal Chemistry|April 29, 2008
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Chemical Biology & Drug Design|June 19, 2016
Multitargeted bioactive ligands for PPARs discovered in the last decadeJun Zhang, Xin Liu, Xian-Bin Xie, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Advances in assays of matrix metalloproteinases (MMPs) and their inhibitorsXian-Chao Cheng, Hao Fang, Wen-Fang Xu
Current Medicinal Chemistry|February 22, 2008
Role of sulfonamide group in matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Current Medicinal Chemistry|February 22, 2008
Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffoldXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Bromo-1-(3-chloro-pyridin-2-yl)-N-(4-eth-oxy-phen-yl)-1H-pyrazole-5-carbox-amideHai Yue, Wei-Li Dong, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Hy-droxy-methyl-1-(4-meth-oxy-phen-yl)imidazolidine-2,4-dioneXian-Chao Cheng, Jing-Jing Hou, Run-Ling Wang, et al.
European Journal of Medicinal Chemistry|March 26, 2008
Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Methyl 4-(cyclopropylmethoxy)-3-hydroxybenzoate [corrected]Jing-Jing Hou, Xian-Chao Cheng, Run-Ling Wang, et al.
Bioorganic & Medicinal Chemistry|August 23, 2008
Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Bioorganic & Medicinal Chemistry|April 29, 2008
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitorsXian-Chao Cheng, Qiang Wang, Hao Fang, et al.
Chemical Biology & Drug Design|June 19, 2016
Multitargeted bioactive ligands for PPARs discovered in the last decadeJun Zhang, Xin Liu, Xian-Bin Xie, et al.
Pageof 4